Overview

Inhaled Iloprost in Mild Asthma

Status:
Completed

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine if inhaled iloprost given four times daily can improve symptoms and lung function in adults with mild asthma.

Phase:

Early Phase 1

Details

Lead Sponsor:

Vanderbilt University

Collaborator:

Actelion

Treatments:

Iloprost